Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
- Sponsored Content
- QA/QC
- Risk Management
- Viral Clearance
BPI Contributor
December 12, 2018
1 Min Read
Sponsored by Eurofins Biopharma
Expect the expected. But plan for the unexpected. If your Biosafety Development takes a nose dive, Eurofins Lancaster Laboratories’ team of regulatory experts and experienced scientists will help you land safely on two feet. Download The Complete e-Book of Biosafety Testing to learn more about our expertise in biologics raw materials, cell bank preparation, adventitious virus testing, viral clearance studies, next-generation sequencing, genetic stability testing, and more.
This e-Book contains the following chapters:
Mitigating Risk and Reducing Regulatory Scrutiny of Biologics Raw Materials — Andrew D. Schaefer and Terry Schuck
The Importance of Proper Cryopreservation of Cells for Cell Bank Preparation — Svetlana Mogilyanskiy
Need to Test Viral Products for Adventitious Viruses? — Katherine Marotte
Viral Clearance Studies — Doug Rea
Next-Generation Sequencing Revolutionizes Adventitious Virus Detection — Jeri Ann Boose and Thomas Brefort
Compendial Quality and Function Testing of Fetal Bovine Serum — Heather Beyer and Andrew D. Schaefer
Genetic Stability Testing Ensures Product Integrity — Weihong Wang
Just fill out this form to download The Complete eBook of Biosafety Testing now.
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More